Revolutionizing IVF
with Metabolomics
Embryomic, a MetaProme company, was established in 2022 with the ambition to transform the way IVF is understood and applied in clinical practice.
We are experts in systems biology committed to help clinicians, embryologists and patients in the process of reducing time to pregnancy.
Years of novel research has taken us where we are today. PMT-BC is the culmination of extraordinary scientific work in the field of metabolomics.
What is MetaProme?
MetaProme – Group company dedicated to advance research in proteomics and metabolomics across different therapy areas, including femtech, oncology, haematology, metabolic syndrome.
Our Team
Robert Brennan
Founding Partner and CEO
robert.brennan@www.embryomic.com
Over 15 years’ commercial experience
in finance and medical testing inc.
RDT Care & Davy…
Prof Ray Iles
Founding Partner and Chief Scientific Officer
ray.iles@www.embryomic.com
Held numerous positions in academia
including visiting Professor at University
of Cambridge…..
Dr. Sara Nasser
Clinical Lead
sara@www.embryomic.com
As a trained Obstetrician and Gynecologist subspecializing in gynecological oncology, she has practiced across Italy, Germany, and the UK.
Our Lab
The main Embryomic lab was established at the Dublin City University (DCU) Innovation Campus in 2024. It incorporates the latest technology in Mass Spectrometry available in the market.
Our Journey
